Table 2.

Baseline Characteristics for Each Subgroup

CharacteristicCOPD
(n = 65)
Asthma
(n = 62)
T2D
(n = 60)
Male sex, No. (%)39 (60.0)19 (30.6)30 (50.0)
Age, mean (SD), y66 (6.9)56 (13.4)66 (9.5)
Highest level of education, No. (%)a
    Lowb26 (40.0)18 (29.0)29 (48.3)
    Middlec  3 (4.6)10 (16.1)  6 (10.0)
    Highd36 (55.4)34 (54.8)25 (41.7)
Diagnosed since, No. (%), y
    <1  1 (1.5)  1 (1.6)  1 (1.7)
    1-3  4 (6.2)  4 (6.5)
    >360 (92.357 (91.9)
    1-1540 (66.7)
    >1519 (31.7)
Smoking status, No. (%)
    Never  6 (9.2)34 (54.8)
    Former58 (89.2)28 (45.2)
    Current  1 (1.5)  0 (0.0)
Treated by, No. (%)
    General practitioner11 (17.5)17 (31.5)48 (82.8)
    Medical specialist52 (82.5)37 (68.5)10 (17.2)
    Unknown  2  8  2
Exacerbations, previous year, No. (%)
    019 (29.2)16 (25.8)
    119 (29.2)  8 (12.9)
    2  9 (13.8)15 (24.2)
    >218 (27.7)23 (37.1)
Medication, No. (%)
No medication  0 (0.0)  1 (1.6)  5 (8.3)
Any of the following:
    SABA/SAMA40 (61.5)45 (72.6)
    LABA/LAMA49 (75.4)22 (35.5)
    ICS17 (26.2)37 (59.7)
    Combination medication (ICS + LABA/LAMA)35 (53.8)43 (69.4)
    Metformin40 (66.7)
    Gliclazide, glimepiride, or tolbutamide22 (36.7)
    Insulin27 (45.0)
  • COPD = chronic obstructive pulmonary disease; ICS = inhaled corticosteroids; LABA = long-acting β2-agonist; LAMA = long-acting muscarinic antagonists; SABA = short-acting β2-agonist; SAMA = short-acting muscarinic antagonists; T2D = type 2 diabetes.

  • a According to the Education Systems in the Netherlands.39

  • b Elementary school, pre-vocational secondary education and training, or secondary vocational education and training.

  • c Senior general secondary education or pre-university education.

  • d Higher professional education or university education.